{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T12:22:05Z","timestamp":1773404525077,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["111298"],"award-info":[{"award-number":["111298"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["111299"],"award-info":[{"award-number":["111299"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017515","name":"Heidelberger Stiftung Chirurgie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017515","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["031A213"],"award-info":[{"award-number":["031A213"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005941","name":"Dietmar Hopp Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005941","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.canlet.2015.10.039","type":"journal-article","created":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T07:00:38Z","timestamp":1448866838000},"page":"134-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Restoration of miR-127-3p and miR-376a-3p counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells by targeting COA1, GLE1 and PDIA6"],"prefix":"10.1016","volume":"371","author":[{"given":"J\u00f6rg","family":"Fellenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiner","family":"S\u00e4hr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhefu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Tichy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Herr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2015.10.039_bib0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.anndiagpath.2007.09.002","article-title":"Clinicopathologic profile of 470 giant cell tumors of bone from a cancer hospital in western India","volume":"12","author":"Gupta","year":"2008","journal-title":"Ann. Diagn. Pathol"},{"key":"10.1016\/j.canlet.2015.10.039_bib0015","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s004320100234","article-title":"The nature of giant cell tumor of bone","volume":"127","author":"Wulling","year":"2001","journal-title":"J. Cancer Res. Clin. Oncol"},{"key":"10.1016\/j.canlet.2015.10.039_bib0020","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00432-008-0370-x","article-title":"Giant cell tumor of bone: treatment and outcome of 214 cases","volume":"134","author":"Balke","year":"2008","journal-title":"J. Cancer Res. Clin. Oncol"},{"key":"10.1016\/j.canlet.2015.10.039_bib0025","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s11999-009-0966-8","article-title":"Metastatic giant cell tumor of bone: are there associated factors and best treatment modalities?","volume":"468","author":"Viswanathan","year":"2010","journal-title":"Clin. Orthop. Relat. Res"},{"key":"10.1016\/j.canlet.2015.10.039_bib0030","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00003086-199702000-00026","article-title":"Analysis of giant cell tumor of bone with pulmonary metastases","author":"Osaka","year":"1997","journal-title":"Clin. Orthop. Relat. Res"},{"key":"10.1016\/j.canlet.2015.10.039_bib0035","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.2106\/JBJS.D.02771","article-title":"Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy","volume":"90","author":"Becker","year":"2008","journal-title":"J. Bone Joint Surg. Am"},{"key":"10.1016\/j.canlet.2015.10.039_bib0040","first-page":"206","article-title":"Curettage of giant cell tumor of bone. The effect of surgical technique and adjuvants on local recurrence rate","volume":"75","author":"Capanna","year":"1990","journal-title":"Chir. Organi Mov"},{"key":"10.1016\/j.canlet.2015.10.039_bib0045","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/1471-2407-10-462","article-title":"Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone","volume":"10","author":"Balke","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2015.10.039_bib0050","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1470-2045(10)70010-3","article-title":"Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study","volume":"11","author":"Thomas","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canlet.2015.10.039_bib0055","first-page":"983","article-title":"The origin of the neoplastic stromal cell in giant cell tumor of bone","volume":"34","author":"Wulling","year":"2003","journal-title":"Hum. Pathol"},{"key":"10.1016\/j.canlet.2015.10.039_bib0060","first-page":"2520","article-title":"Quantitative immunofluorescence studies of the tumor antigen-bearing cell in giant cell tumor of bone and osteogenic sarcoma","volume":"35","author":"Byers","year":"1975","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.10.039_bib0065","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/jso.23151","article-title":"Stro-1(+) stromal cells have stem-like features in giant cell tumor of bone","volume":"106","author":"Lan","year":"2012","journal-title":"J. Surg. Oncol"},{"key":"10.1016\/j.canlet.2015.10.039_bib0070","doi-asserted-by":"crossref","first-page":"e1471","DOI":"10.1038\/cddis.2014.440","article-title":"Enrichment of c-Met+ tumorigenic stromal cells of giant cell tumor of bone and targeting by cabozantinib","volume":"5","author":"Liu","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.canlet.2015.10.039_bib0075","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/BLO.0b013e31804856a1","article-title":"Properties of the stromal cell in giant cell tumor of bone","volume":"459","author":"Ghert","year":"2007","journal-title":"Clin. Orthop. Relat. Res"},{"key":"10.1016\/j.canlet.2015.10.039_bib0080","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bone.2003.10.013","article-title":"Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone","volume":"34","author":"Huang","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.canlet.2015.10.039_bib0085","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.canlet.2012.01.043","article-title":"A microRNA signature differentiates between giant cell tumor derived neoplastic stromal cells and mesenchymal stem cells","volume":"321","author":"Fellenberg","year":"2012","journal-title":"Cancer Lett"},{"key":"10.1016\/j.canlet.2015.10.039_bib0090","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2015.10.039_bib0095","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1261\/rna.5248604","article-title":"Fast and effective prediction of microRNA\/target duplexes","volume":"10","author":"Rehmsmeier","year":"2004","journal-title":"RNA"},{"key":"10.1016\/j.canlet.2015.10.039_bib0100","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000071273","article-title":"Giant cell tumor of bone. The role of fibroblast growth factor 3 positive mesenchymal stem cells in its pathogenesis","volume":"70","author":"Robinson","year":"2002","journal-title":"Pathobiology"},{"key":"10.1016\/j.canlet.2015.10.039_bib0105","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/gcc.20667","article-title":"Cytogenetic analysis of 101 giant cell tumors of bone: nonrandom patterns of telomeric associations and other structural aberrations","volume":"48","author":"Gorunova","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.canlet.2015.10.039_bib0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/0165-4608(92)90125-R","article-title":"Giant cell tumor of bone. Chromosomal analysis of 48 specimens and review of the literature","volume":"58","author":"Bridge","year":"1992","journal-title":"Cancer Genet. Cytogenet"},{"key":"10.1016\/j.canlet.2015.10.039_bib0115","first-page":"187","article-title":"Cytogenetic analysis of giant cell tumors of bone; diagnostic and prognostic implications","volume":"75","author":"Bridge","year":"1990","journal-title":"Chir. Organi Mov"},{"key":"10.1016\/j.canlet.2015.10.039_bib0120","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/ng.2814","article-title":"Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone","volume":"45","author":"Behjati","year":"2013","journal-title":"Nat. Genet"},{"key":"10.1016\/j.canlet.2015.10.039_bib0125","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1101\/gad.217778.113","article-title":"The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression","volume":"27","author":"Chan","year":"2013","journal-title":"Genes Dev"},{"key":"10.1016\/j.canlet.2015.10.039_bib0130","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.1232245","article-title":"Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma","volume":"340","author":"Lewis","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.canlet.2015.10.039_bib0135","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/1471-2407-14-495","article-title":"Epigenetic silencing of genes and microRNAs within the imprinted Dlk1-Dio3 region at human chromosome 14.32 in giant cell tumor of bone","volume":"14","author":"Lehner","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2015.10.039_bib0140","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/sj.bjc.6602478","article-title":"Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour","volume":"92","author":"Astuti","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2015.10.039_bib0145","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.ajpath.2011.07.002","article-title":"Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomas","volume":"179","author":"Cheunsuchon","year":"2011","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.canlet.2015.10.039_bib0150","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/401986","article-title":"Prognostic and biological significance of microRNA-127 expression in human breast cancer","volume":"2014","author":"Wang","year":"2014","journal-title":"Dis. Markers"},{"key":"10.1016\/j.canlet.2015.10.039_bib0155","doi-asserted-by":"crossref","first-page":"14171","DOI":"10.3390\/ijms140714171","article-title":"The tumor suppressor roles of miR-433 and miR-127 in gastric cancer","volume":"14","author":"Guo","year":"2013","journal-title":"Int. J. Mol. Sci"},{"key":"10.1016\/j.canlet.2015.10.039_bib0160","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1038\/sj.emboj.7601861","article-title":"Coa1 links the Mss51 post-translational function to Cox1 cofactor insertion in cytochrome c oxidase assembly","volume":"26","author":"Pierrel","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2015.10.039_bib0165","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1093\/hmg\/ddp370","article-title":"A conserved role for the mitochondrial citrate transporter Sea\/SLC25A1 in the maintenance of chromosome integrity","volume":"18","author":"Morciano","year":"2009","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.canlet.2015.10.039_bib0170","doi-asserted-by":"crossref","first-page":"9523","DOI":"10.7314\/APJCP.2014.15.21.9523","article-title":"Expression and clinical significance of microRNA-376a in colorectal cancer","volume":"15","author":"Mo","year":"2014","journal-title":"Asian Pac. J. Cancer Prev"},{"key":"10.1016\/j.canlet.2015.10.039_bib0175","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1038\/onc.2013.451","article-title":"MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells","volume":"33","author":"Formosa","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2015.10.039_bib0180","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.febslet.2012.05.054","article-title":"miR-376a suppresses proliferation and induces apoptosis in hepatocellular carcinoma","volume":"586","author":"Zheng","year":"2012","journal-title":"FEBS Lett"},{"key":"10.1016\/j.canlet.2015.10.039_bib0185","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1476-4598-11-44","article-title":"Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor","volume":"11","author":"Zehavi","year":"2012","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2015.10.039_bib0190","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.cell.2008.06.027","article-title":"The mRNA export factor Gle1 and inositol hexakisphosphate regulate distinct stages of translation","volume":"134","author":"Bolger","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2015.10.039_bib0195","doi-asserted-by":"crossref","first-page":"6960","DOI":"10.4238\/2015.June.26.4","article-title":"PDIA3 and PDIA6 gene expression as an aggressiveness marker in primary ductal breast cancer","volume":"14","author":"Ramos","year":"2015","journal-title":"Genet. Mol. Res"},{"key":"10.1016\/j.canlet.2015.10.039_bib0200","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/cdd.2013.193","article-title":"The protein disulfide isomerases PDIA4 and PDIA6 mediate resistance to cisplatin-induced cell death in lung adenocarcinoma","volume":"21","author":"Tufo","year":"2014","journal-title":"Cell Death Differ"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383515007077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383515007077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T18:17:11Z","timestamp":1656353831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383515007077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0304383515007077"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2015.10.039","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Restoration of miR-127-3p and miR-376a-3p counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells by targeting COA1, GLE1 and PDIA6","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2015.10.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}